Weekly insulin shot could replace daily injections for diabetes
NCT ID NCT06767761
First seen Jan 10, 2026 · Last updated May 22, 2026 · Updated 24 times
Summary
This study tests a new insulin called GZR4 that is given once a week, compared to a standard daily insulin (glargine). Both groups also use a fast-acting insulin at meals. The goal is to see if the weekly shot works as well or better at controlling blood sugar, with fewer side effects. About 580 adults with type 2 diabetes who already use daily insulin are taking part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Second XIANGYA Hospital Of Central South University
Changsha, Hunan, 410011, China
Conditions
Explore the condition pages connected to this study.